Abiopharma

Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research

Masco Corporation Announces Date for Earnings Release and Conference Call for 2026 First Quarter

Sapu Nano to Present Everolimus Toxicology Data at SOT 2026 Annual Meeting

Phillips 66 to announce first-quarter financial results

Fusion Fuel Approves Appointment of Uranium Investor James Passin to Board as Company Undertakes Uranium Royalty Strategy

Western Asset Municipal High Income Fund Inc. Announces Financial Position as of January 31, 2026

Humacyte To Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026

Riskified Announces Board Changes and Appoints Dr. Samer Haj-Yehia to Board of Directors

InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer’s Disease Program

Change in holdings of interested parties/officers